Goldman Sachs’s Athenahealth, Inc. ATHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-15,100
| Closed | -$2.4M | – | 5945 |
|
|
2018
Q2 | $2.4M | Buy |
+15,100
| New | +$2.24M | ﹤0.01% | 3519 |
|
|
2018
Q1 | – | Sell |
-10,500
| Closed | -$1.4M | – | 6614 |
|
|
2017
Q4 | $1.4M | Sell |
10,500
-16,400
| -61% | -$2.1M | ﹤0.01% | 4072 |
|
|
2017
Q3 | $3.35M | Sell |
26,900
-900
| -3% | -$124K | ﹤0.01% | 3520 |
|
|
2017
Q2 | $3.91M | Buy |
27,800
+15,200
| +121% | +$1.9M | ﹤0.01% | 3267 |
|
|
2017
Q1 | $1.42M | Sell |
12,600
-66,200
| -84% | -$7.72M | ﹤0.01% | 4070 |
|
|
2016
Q4 | $8.29M | Buy |
78,800
+71,500
| +979% | +$7.69M | ﹤0.01% | 2603 |
|
|
2016
Q3 | $921K | Sell |
7,300
-42,100
| -85% | -$5.36M | ﹤0.01% | 4481 |
|
|
2016
Q2 | $6.82M | Buy |
49,400
+40,300
| +443% | +$5.33M | ﹤0.01% | 2614 |
|
|
2016
Q1 | $1.26M | Sell |
9,100
-20,200
| -69% | -$2.77M | ﹤0.01% | 3883 |
|
|
2015
Q4 | $4.72M | Sell |
29,300
-11,100
| -27% | -$1.71M | ﹤0.01% | 2875 |
|
|
2015
Q3 | $5.39M | Buy |
40,400
+5,200
| +15% | +$678K | ﹤0.01% | 2817 |
|
|
2015
Q2 | $4.03M | Buy |
35,200
+700
| +2% | +$83.7K | ﹤0.01% | 3154 |
|
|
2015
Q1 | $4.12M | Sell |
34,500
-26,800
| -44% | -$3.57M | ﹤0.01% | 3089 |
|
|
2014
Q4 | $8.93M | Sell |
61,300
-2,200
| -3% | -$276K | ﹤0.01% | 2446 |
|
|
2014
Q3 | $8.36M | Sell |
63,500
-8,400
| -12% | -$1.11M | ﹤0.01% | 2518 |
|
|
2014
Q2 | $9M | Sell |
71,900
-2,900
| -4% | -$375K | ﹤0.01% | 2460 |
|
|
2014
Q1 | $12M | Sell |
74,800
-48,200
| -39% | -$7.93M | ﹤0.01% | 2209 |
|
|
2013
Q4 | $16.5M | Buy |
123,000
+24,500
| +25% | +$3.15M | 0.01% | 1906 |
|
|
2013
Q3 | $10.7M | Sell |
98,500
-12,500
| -11% | -$1.35M | ﹤0.01% | 2181 |
|
|
2013
Q2 | $9.4M | Buy |
+111,000
| New | +$9.93M | ﹤0.01% | 2156 |
|
Goldman Sachs's ATHN Position: Q1 2019 in Review
Goldman Sachs sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 350,030 shares — an estimated $46.2M sold.
Goldman Sachs first reported a position in ATHN in Q2 2013 and held it in 23 quarters. The position peaked at $89.3M in Q2 2017. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.
- Goldman Sachs reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
- Goldman Sachs sold 350,030 Athenahealth, Inc. shares in Q1 2019, an estimated $46.2M.
- Goldman Sachs first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 23 quarters.
- Goldman Sachs's Athenahealth, Inc. position peaked at $89.3M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.
Based on Goldman Sachs's 13F filing for Q1 2019, filed 15 May 2019.